The global nalbuphine hydrochloride market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Nalbuphine HCL (Nalbuphine hydrochloride) or commonly known as nubain, belongs to a group of opioid analgesics, is a narcotic pain reliever used to treat moderate to severe pain as well as treats opioid addiction. Adding to this, nubain is also used in treatment of pain just after childbirth or surgery. Thus, the growing application of the drug is anticipated to provide a boost to the market growth. Another major factor likely to propel the market growth includes the widespread regulatory approval and efficacy, with considerably less capacity for euphoria or any respiratory depression in comparison to other opioids. This attribute of the drug has made it convenient for the drug suppliers and manufacturers to commercialize it under various company brand names including Mexifen, Nalbuphine, Nalpain, Kinz, Nalufin, Raltrox, Rubuphine, Nalbin, Analin, and Exnal, among others.
To Request a Sample of our Report on Global Nalbuphine Hydrochloride Market: https://www.omrglobal.com/request-sample/nalbuphine-hydrochloride-market
The global nalbuphine hydrochloride market is segmented based on type and application. On the basis of type, the market is sub segmented into adult and children. Among both these types, the adult segment is likely to show a prominent growth owing to a comparatively higher demand. Since the medicine is a composition of narcotic pain reliever, it is only recommended to children in exclusively severe medical conditions. Whereas on the basis of application, the market is further segmented into hospital, pharmacy, and others. Among all of these, the pharmacy sub segment is anticipated to hold a substantial market share, owing to the significant demand for the drug attributed to its widespread regulatory approval and efficacy.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Glenmark Pharmaceuticals Ltd., Pfizer Inc., and Abbott Laboratories, among others.
A full Report of Global Nalbuphine Hydrochloride Market is Available @ https://www.omrglobal.com/industry-reports/nalbuphine-hydrochloride-market
Global Nalbuphine Hydrochloride Market Report by Segment
By Type
- Adult
- Children
By Application
- Hospital
- Pharmacy
- Others
Global Nalbuphine Hydrochloride Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/nalbuphine-hydrochloride-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
